Publisher
Springer International Publishing
Reference18 articles.
1. A.M. Best (2022) Private equity continues to make inroads in life/annuity segment. Best’s special report
2. Braun RT, Bond AM, Qian Y, Zhang M, Casalino LP (2021) Private equity in dermatology: effect on price, utilization, and spending: study examines the prevalence of private equity acquisitions and their impact on dermatology prices, spending, use, and volume of patients. Health Aff 40(5):727–735
3. Bruch JD, Gondi S, Song Z (2020) Changes in hospital income, use, and quality associated with private equity acquisition. JAMA Intern Med 180(11):1428–1435
4. Creadore A, Desai S, Li SJ, Lee KJ, Bui A-TN, Villa-Ruiz C, Lo K et al (2021) Insurance acceptance, appointment wait time, and dermatologist access across practice types in the US. JAMA Dermatol 157(2):181–188
5. Eager, Davis, Holmes (2012) Fees paid for third party insurance asset management. Available at: http://eagerdavisholmes.com/Index.cfm?Page=Publications&Content=Research